Enlivex Therapeutics (NASDAQ:ENLV) Earns “Buy” Rating from D. Boral Capital
D. Boral Capital restated their buy rating on shares of Enlivex Therapeutics (NASDAQ:ENLV – Free Report) in a research note released on Friday morning,Benzinga reports. They currently have a $13.00 target price on the stock. Enlivex Therapeutics Stock Up 6.8 % Shares of Enlivex Therapeutics stock opened at $1.10 on Friday. Enlivex Therapeutics has a […]
D. Boral Capital restated their buy rating on shares of Enlivex Therapeutics (NASDAQ:ENLV – Free Report) in a research note released on Friday morning,Benzinga reports. They currently have a $13.00 target price on the stock. Enlivex Therapeutics Stock Up 6.8 % Shares of Enlivex Therapeutics stock opened at $1.10 on Friday. Enlivex Therapeutics has a […]
